🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, prospective study. The main purpose is to evaluate ...
Status
Not Yet Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-07
Trial ID
NCT07008053
Treatments Being Tested
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
This is a single-arm, prospective clinical study to evaluate the efficacy a...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-03-11
Trial ID
NCT07022223
Treatments Being Tested
This is a multicenter, open-label, single-arm, prospective clinical study o...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-02-07
Trial ID
NCT07410520
Treatments Being Tested
In patients with previously untreated Marginal zone lymphoma (MZL), a treat...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Start Date
2025-10-01
Trial ID
NCT07480863
Treatments Being Tested
A multicenter, randomized, prospective clinical study of the efficacy and s...
Status
Unknown
Location
Ruijin Hospital
Start Date
2021-12-01
Trial ID
NCT05334238
Treatments Being Tested
This is a single arm, single center, open label pilot study of Orelabrutini...
Status
Completed
Location
Department of Hematology, Huashan Hospital, Fudan University
Start Date
2021-10-10
Trial ID
NCT05036577
Treatments Being Tested
Assess the preliminary efficacy and safety of orelabrutinib in combination ...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-05-05
Trial ID
NCT07078500
Treatments Being Tested
This phase 2 trial studies the efficacy and safety of orelabrutinib plus ri...
Status
Recruiting
Location
Guangdong General Hospital
Start Date
2021-08-01
Trial ID
NCT04989621
Treatments Being Tested
The goal of this clinical trial is to test the overall response rate of Ore...
Status
Recruiting
Location
The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital
Start Date
2023-01-02
Trial ID
NCT06134284
Treatments Being Tested